Nontraditional dosing of ampicillin-sulbactam for multidrug-resistant Acinetobacter baumannii meningitis

Pharmacotherapy

Volumn 22, Issue 4, 2002, Pages 527-532

  Cawley, Michael J ^a   Suh, Caroline ^b   Lee, Susanne ^c   Ackerman, Bruce H ^d  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^c Scientific Therapeutics Information Inc   (United States)

^d CROZER CHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFAZOLIN; CILASTATIN PLUS IMIPENEM; DEXAMETHASONE; FAMOTIDINE; GENTAMICIN; LORAZEPAM; MANNITOL; PHENOBARBITAL; PHENYLEPHRINE; PHENYTOIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; ANTERIOR COMMUNICATING ARTERY; ARTICLE; BACTERIAL MENINGITIS; CASE REPORT; CEREBROSPINAL FLUID CULTURE; CONFUSION; DRUG MEGADOSE; FALLING; FEMALE; HEADACHE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NAUSEA; PHOTOPHOBIA; SUBARACHNOID HEMORRHAGE; TONIC CLONIC SEIZURE; VERTIGO; VOMITING;

ACINETOBACTER; ACINETOBACTER INFECTIONS; AMPICILLIN; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; DRUG THERAPY, COMBINATION; HUMANS; MALE; MENINGITIS, BACTERIAL; MIDDLE AGED; SULBACTAM;

EID: 0036205768     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.22.7.527.33676     Document Type: Article

References (31)

1. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical, and epidemiological features
2. Antibiotic-resistant Acinetobacter meningitis in neurosurgical patients
3. Nosocomial infections due to Acinetobacter baumannii in a neurosurgery ICU
4. Nosocomial Acinetobacter meningitis secondary to invasive procedures: Report of 25 cases and review
5. Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii
6. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam
7. Intravenous colistin as therapy for nosocomial infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii
8. Pharmacokinetics of sulbactam/ampicillin in humans: A review
9. An outbreak of Acinetobacter respiratory tract infection resulting from incomplete disinfection of ventilatory equipment
10. Room humidifiers as the source of Acinetobacter infections
11. An outbreak of infections with Acinetobacter calcoaceticus in burn patients: Contamination of patients' mattresses
12. An outbreak of Acinetobacter baumannii: The importance of cross-transmission
13. Evaluation of Acinetobacter baumannii infection and colonization, and antimicrobial treatment patterns in an urban teaching hospital
14. The prognostic factors of adult gram-negative bacillary meningitis
15. Endemic carbapenem-resistant Acinetobacter species in Brooklyn, New York: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage
16. Epidemiology, resistance, and outcomes of Acinetobacter baumannii bacteremia treated with imipenem-cilastatin or ampicillin-sulbactam
17. In vitro activities of nontraditional antimicrobials against multiresistant Acinetobacter baumannii strains isolated in an intensive care unit outbreak
18. In vitro activity of ampicillin-sulbactam against clinical multiresistant Acinetobacter baumannii isolates
19. Sulbactam: Biochemical factors involved in its synergy with ampicillin
20. In vitro evaluations of aminopenicillin/β-lactamase inhibitor combinations
21. Penetration of sulbactam into the cerebrospinal fluid of patients with bacterial meningitis receiving ampicillin therapy
22. Treatment of multidrug-resistant Acinetobacter baumannii meningitis with ampicillin/sulbactam
23. Treatment of severe infection by multiresistant Acinetobacter baumannii (MRAB) with ampicillin/sulbactam-preliminary report
24. Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium
25. Sulbactam/ampicillin vs. chloramphenicol/ampicillin for the treatment of meningitis in infants and children
26. Bactericidal in-vitro activity of β-lactam and β-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: Effect of combination with aminoglycosides
27. Comparative in vitro antimicrobial susceptibilities of nosocomial isolates of Acinetobacter baumannii and synergistic activities of nine antimicrobial combinations
28. Successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with intravenous colistin sulfomethate sodium
29. Antimicrobial agents and the central nervous system
30. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium
31. Successful treatment of ceftazidime-resistant Klebsiella pneumoniae ventriculitis with intravenous meropenem and intraventricular polymyxin B: Case report and review